{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-385910","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2026-09-09T12:00:12+00:00","discovered_at":"2026-09-09T12:05:00.295844+00:00","generated_at":"2026-09-09T12:05:33.363085+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Tenax presents LEVEL clinical trial results at Cantor conference; data not in filing text","bullets":["Tenax Therapeutics (TENX) presented at 2026 Cantor Global Healthcare Conference on Sept 9, 2026.","Presentation titled 'LEVEL Clinical Trial Results' was published on company website and attached as Exhibit 99.1.","Filing text contains only the presentation title slide; actual trial results are not included in the 8-K text."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-385910","json":"https://secwatch.observer/filing/0001193125-26-385910.json","markdown":"https://secwatch.observer/filing/0001193125-26-385910.md","text":"https://secwatch.observer/filing/0001193125-26-385910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/0001193125-26-385910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/d43255d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T12:05:33.363085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}